| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Division of Endocrinology and Metabolism, Departments of Medicine (J.Q., S.M., T.N., J.A.F., T.L.C.) and Molecular and Cellular Physiology (J.N.L., R.L.S., C.W., R.J.P., J.A.F., T.L.C.), University of Cincinnati, and the Department of Pediatrics, Childrens Hospital (M.C.C.), Cincinnati, Ohio 45267
Address all correspondence and requests for reprints to: Thomas L. Clemens, Ph.D., Division of Endocrinology and Metabolism, University of Cincinnati, Room 5564, 231 Bethesda Avenue, Cincinnati, Ohio 45267-0547. E-mail: clementl{at}uc.edu
PTH-related protein (PTHrP) is produced in vascular smooth muscle, where it is postulated to exert vasorelaxant properties by activation of the PTH/PTHrP type 1 receptor. As a model for studying the actions of locally produced PTHrP in vascular smooth muscle in vivo, we developed transgenic mice that overexpress the PTH/PTHrP receptor (PTHrP-R) in smooth muscle. Oocyte injection with a SMP8-PTHrP-R fusion construct yielded six founder mice. F1 offspring were viable and demonstrated selective overexpression of the SMP8-PTHP-R messenger RNA in smooth muscle-rich tissues. Baseline blood pressure measured in conscious mice by tail sphygmomanometry was significantly lower in the receptor-overexpressing mice than that in controls (117 ± 4 vs. 133 ± 3 mm Hg; P < 0.05). In anesthetized animals, iv infusion of PTHrP-(134)NH2 caused a significantly greater reduction in blood pressure and total peripheral resistance in transgenic mice than in control animals. Vascular contractility was studied in paired, isometrically mounted aortas from 9-week-old transgenic and wild-type mice. The force of contraction in response to phenlyephrine was not significantly different between transgenic and wild-type mice. However, PTHrP-(134) NH2 relaxed aortic vessel preparations from transgenic mice to a greater extent than in controls (77.1 ± 3% vs. 38.4 ± 4%; P < 0.001). To determine the impact of overexpression of PTH/PTHrP type 1 receptor and its ligand on the development of the cardiovascular system, double transgenic mice were created by crossing SMP8-PTHrP-R transgenic mice with mice overexpressing PTHrP (SMP8-PTHrP). Double transgenic mice died around day E9 with abnormalities in the developing heart. In conclusion, overexpression of PTH/PTHrP type 1 receptor in vascular smooth muscle of transgenic mice reduces blood pressure, probably through sustained activation of the receptor by endogenous ligand. The cardiovascular defects observed in mice overexpressing both PTHrP and its receptor suggest that PTHrP may play a role in the normal development of the cardiovascular system.
This article has been cited by other articles:
![]() |
S. Welsch, E. Schordan, C. Coquard, T. Massfelder, N. Fiaschi-Taesch, J.-J. Helwig, and M. Barthelmebs Abnormal Renovascular Parathyroid Hormone-1 Receptor in Hypertension: Primary Defect or Secondary to Angiotensin II Type 1 Receptor Activation? Endocrinology, September 1, 2006; 147(9): 4384 - 4391. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Mullins, M. A. Bailey, and J. J. Mullins Hypertension, Kidney, and Transgenics: A Fresh Perspective Physiol Rev, April 1, 2006; 86(2): 709 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen, W. Stuart, B. Hu, L. Nguyen, G. Huang, T. L. Clemens, and J. S. Adams Creation of Estrogen Resistance in Vivo by Transgenic Overexpression of the Heterogeneous Nuclear Ribonucleoprotein-Related Estrogen Response Element Binding Protein Endocrinology, October 1, 2005; 146(10): 4266 - 4273. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fritsch, V. Lindner, S. Welsch, T. Massfelder, M. Grima, S. Rothhut, M. Barthelmebs, and J.-J. Helwig Intravenous Delivery of PTH/PTHrP Type 1 Receptor cDNA to Rats Decreases Heart Rate, Blood Pressure, Renal Tone, Renin Angiotensin System, and Stress-Induced Cardiovascular Responses J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2588 - 2600. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fiaschi-Taesch, K. K. Takane, S. Masters, J. C. Lopez-Talavera, and A. F. Stewart Parathyroid Hormone-Related Protein as a Regulator of pRb and the Cell Cycle in Arterial Smooth Muscle Circulation, July 13, 2004; 110(2): 177 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Noonan, J. Qian, W. D. Stuart, T. L. Clemens, and J. N. Lorenz Altered Renal Hemodynamics in Mice Overexpressing the Parathyroid Hormone (PTH)/PTH-Related Peptide Type 1 Receptor in Smooth Muscle Endocrinology, November 1, 2003; 144(11): 4931 - 4938. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Qian, M. C. Colbert, D. Witte, C.-Y. Kuan, E. Gruenstein, H. Osinska, B. Lanske, H. M. Kronenberg, and T. L. Clemens Midgestational Lethality in Mice Lacking the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Is Associated with Abrupt Cardiomyocyte Death Endocrinology, March 1, 2003; 144(3): 1053 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cebrian, A. Garcia-Ocana, K. K. Takane, D. Sipula, A. F. Stewart, and R. C. Vasavada Overexpression of Parathyroid Hormone-Related Protein Inhibits Pancreatic {beta}-Cell Death In Vivo and In Vitro Diabetes, October 1, 2002; 51(10): 3003 - 3013. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Eichinger, N. Fiaschi-Taesch, T. Massfelder, S. Fritsch, M. Barthelmebs, and J.-J. Helwig Transcript Expression of the Tuberoinfundibular Peptide (TIP)39/PTH2 Receptor System and Non-PTH1 Receptor-Mediated Tonic Effects of TIP39 and Other PTH2 Receptor Ligands in Renal Vessels Endocrinology, August 1, 2002; 143(8): 3036 - 3043. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Lorenz A practical guide to evaluating cardiovascular, renal, and pulmonary function in mice Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1565 - R1582. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Massfelder, N. Taesch, S. Fritsch, A. Eichinger, M. Barthelmebs, A. F. Stewart, and J.-J. Helwig Type 1 Parathyroid Hormone Receptor Expression Level Modulates Renal Tone and Plasma Renin Activity in Spontaneously Hypertensive Rat J. Am. Soc. Nephrol., March 1, 2002; 13(3): 639 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Clemens, J. Qian, and M. C. Colbert Editorial: Prenatal Lethality in PTH Type I Receptor Null Mice--Interrogating the Usual Suspects Endocrinology, December 1, 2001; 142(12): 5056 - 5058. [Full Text] [PDF] |
||||
![]() |
D. W. Soegiarto, S. Kiachopoulos, E. Schipani, H. Juppner, R. G. Erben, and B. Lanske Partial Rescue of PTH/PTHrP Receptor Knockout Mice by Targeted Expression of the Jansen Transgene Endocrinology, December 1, 2001; 142(12): 5303 - 5310. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. de Miguel, N. Fiaschi-Taesch, J. C. Lopez-Talavera, K. K. Takane, T. Massfelder, J.-J. Helwig, and A. F. Stewart The C-Terminal Region of PTHrP, in Addition to the Nuclear Localization Signal, Is Essential for the Intracrine Stimulation of Proliferation in Vascular Smooth Muscle Cells Endocrinology, September 1, 2001; 142(9): 4096 - 4105. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mizuno, N. Ono, and T. Ohhashi Parathyroid hormone-related protein-(1-34) inhibits intrinsic pump activity of isolated murine lymph vessels Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H60 - H66. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Wysolmerski, S. Cormier, W. M. Philbrick, P. Dann, J.-P. Zhang, J. Roume, A.-L. Delezoide, and C. Silve Absence of Functional Type 1 Parathyroid Hormone (PTH)/PTH-Related Protein Receptors in Humans Is Associated with Abnormal Breast Development and Tooth Impaction J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1788 - 1794. [Abstract] [Full Text] |
||||
![]() |
T. MASSFELDER, N. TAESCH, N. ENDLICH, A. EICHINGER, B. ESCANDE, K. ENDLICH, M. BARTHELMEBS, and J.-J. HELWIG Paradoxical actions of exogenous and endogenous parathyroid hormone-related protein on renal vascular smooth muscle cell proliferation: reversion in the SHR model of genetic hypertension FASEB J, March 1, 2001; 15(3): 707 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Stuart, S. Maeda, P. Khera, J. A. Fagin, and T. L. Clemens Parathyroid hormone-related protein induces G1 phase growth arrest of vascular smooth muscle cells Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E60 - E67. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Faraci and C. D. Sigmund Vascular Biology in Genetically Altered Mice : Smaller Vessels, Bigger Insight Circ. Res., December 3, 1999; 85(12): 1214 - 1225. [Full Text] [PDF] |
||||
![]() |
T. Massfelder and J.-J. Helwig Editorial: Parathyroid Hormone-Related Protein in Cardiovascular Development and Blood Pressure Regulation Endocrinology, April 1, 1999; 140(4): 1507 - 1510. [Full Text] |
||||
![]() |
S. Maeda, R. L. Sutliff, J. Qian, J. N. Lorenz, J. Wang, H. Tang, T. Nakayama, C. Weber, D. Witte, A. R. Strauch, et al. Targeted Overexpression of Parathyroid Hormone-Related Protein (PTHrP) to Vascular Smooth Muscle in Transgenic Mice Lowers Blood Pressure and Alters Vascular Contractility Endocrinology, April 1, 1999; 140(4): 1815 - 1825. [Abstract] [Full Text] |
||||
![]() |
K.-L. Laugwitz, H.-J. Weig, A. Moretti, E. Hoffmann, P. Ueblacker, I. Pragst, K. Rosport, A. Schomig, and M. Ungerer Gene Transfer of Heterologous G Protein-Coupled Receptors to Cardiomyocytes : Differential Effects on Contractility Circ. Res., April 13, 2001; 88(7): 688 - 695. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |